Results 91 to 100 of about 65,460 (210)

CD30 Expression in Neoplastic Mast Cells and the Presence of CD30+, CD3+, and PAX‐5+ Tumour‐Infiltrating Lymphocytes as Prognostic Markers in Canine Cutaneous Mast Cell Tumours

Veterinary and Comparative Oncology, Volume 24, Issue 2, Page 341-352, June 2026.
ABSTRACT Canine cutaneous mast cell tumour (MCT) is the most common skin neoplasm in dogs, with histopathology serving as both the diagnostic and primary prognostic tool. However, identifying reliable biomarkers is essential for improving clinical decision‐making.
Fernanda Ramalho Ramos, Janayna Maria Parente Serafim, Bethânia Almeida Gouveia, Pedro Luiz Porfirio Xavier, Juliano Rodrigues Sangalli, Heidge Fukumasu, Ricardo de Francisco Strefezzi   +6 more
wiley   +1 more source

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia

Case Reports in Medicine, 2014
Mastocytosis is a myeloproliferative neoplasm characterized by clonal expansion of abnormal mast cells, ranging from the cutaneous forms of the disease to mast cell leukemia.
Theodoros Iliakis, Niki Rougkala, Panagiotis T. Diamantopoulos, Vasiliki Papadopoulou, Fani Kalala, Konstantinos Zervakis, Nefeli Giannakopoulou, Polixeni Chatzinikolaou, Georgia Levidou, Eleftheria Lakiotaki, Penelope Korkolopoulou, Efstratios Patsouris, Eleni Variami, Nora-Athina Viniou   +13 more
doaj   +1 more source

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy

Haematologica, 2014
Chronic myeloid leukemia and systemic mastocytosis are myeloid neoplasms sharing a number of pathogenetic and clinical features. In both conditions, an aberrantly activated oncoprotein with tyrosine kinase activity, namely BCR-ABL1 in chronic myeloid ...
Siham Bibi, Melis Dilara Arslanhan, Florent Langenfeld, Sylvie Jeanningros, Sabine Cerny-Reiterer, Emir Hadzijusufovic, Luba Tchertanov, Richard Moriggl, Peter Valent, Michel Arock   +9 more
doaj   +1 more source

Mast Cell Leukemia: Review of a Rare Disease and Case Report of Prolonged Survival after Allogeneic Stem Cell Transplant

Human Pathology: Case Reports, 2017
Mast cell leukemia is a rare and aggressive form of mastocytosis characterized by >20% mast cells found in the bone marrow aspirates of patients with signs of systemic mastocytosis-related organ damage.
James Bauer, MD, PhD, Walter Longo, MD, David Yang, MD   +2 more
doaj   +1 more source

Cladribine therapy for systemic mastocytosis

, 2003
Patients with systemic mastocytosis (SM) can suffer from disabling symptoms related to mast cell mediator release or mast cell infiltration, requiring mast cell eradication.
Gerrits, WBJ, Oldhoff, JM; id_orcid, van Dobbenburgh, OA, Pasmans, SG, Kluin-Nelemans, HC, Fijnheer, R, Verhoef, G, van 't Wout, JW, Oldhoff, JM, van Doormaal, JJ   +9 more
core   +1 more source

Acquired von Willebrand syndrome associated with indolent systemic mastocytosis

, 2020
Hereby we present case report of acquired von Willebrand syndrome (AVWS) in patient with indolent systemic mastocytosis (ISM). Systemic mastocytosis may be considered as a model disease for development of AVWS.
Majeranowski, Alan; Department of Hematology and Transplantology, Medical University of Gdansk, Czarnogórski, Michał; Department of Hematology and Transplantology, Medical University of Gdansk, Janowiak-Majeranowska, Aleksandra; Department of Otolaryngology, Medical University of Gdansk, Mital, Andrzej; Department of Hematology and Transplantology, Medical University of Gdansk, Zawilski, Janusz; Diagnostic and Therapeutic Center InterLab in Poznan   +4 more
core   +1 more source

Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case

Case Reports in Oncological Medicine, 2016
Systemic mastocytosis (SM) is a disease characterized by a clonal infiltration of mast cells affecting various tissues of the body. It is grouped into six different subtypes according to the World Health Organization classification. It is called indolent
Sassine Ghanem, Gwenalyn Garcia, Liu Ying, Matthew Hurford, Marcel Odaimi   +4 more
doaj   +1 more source

Mastocytosis: One Word for Different Diseases

Oncology and Therapy, 2018
Mastocytosis is a neoplastic disease originating from tissue infiltration by transformed mast cells. The diagnosis requires a high grade of suspicion due to the large variety of presenting symptoms. The World Health Organization classification recognizes
Marianna Criscuolo, Luana Fianchi, Alessio M. E. Maraglino, Livio Pagano   +3 more
doaj   +1 more source

Epidemiology of systemic mastocytosis in Denmark

, 2014
Mastocytosis is a heterogeneous group of diseases characterized by abnormal proliferation of mast cells. Systemic mastocytosis (SM), in which abnormal mast cells are present in tissues beyond the skin, is divided into seven subcategories with varying ...
Vestergaard, Hanne, Hoffmann, Stine Skovbo; id_orcid, Bindslev-Jensen, Carsten; id_orcid, Møller, Michael Boe, Cohen, Sarah, Kielsgaard Kristensen, Thomas, Broesby-Olsen, Sigurd, P. Fryzek, Jon   +7 more
core   +1 more source

Systemic mastocytosis with terminal leukemic manifestation in two dogs

Brazilian Journal of Veterinary Pathology, 2017
Systemic mastocytosis (SM) with leukemic manifestation is rarely reported in veterinary patients. Here, we describe two cases of systemic mastocytosis with leukemic spread of neoplastic mast cells in adult dogs, including their clinical signs, clinical ...
Roselene Ecco, Anna L. F. V. Assumpção, Rodrigo M. Couto, Rachel L. A. L. T. Neto, Pâmela C. L. G. Valente, Conrado O. Gamba, Fabiola O. P. Leme, Paulo R. O. Paes   +7 more
doaj   +1 more source